Shihab FS et al. |
Conversion from cyclosporine to tacrolimus in patients at risk for chronic renal allograft failure: 60-month results of the CRAF Study. |
2008 |
Transplantation |
pmid:18475181
|
Shivaswamy V et al. |
Tacrolimus and sirolimus induce reproductive abnormalities in female rats. |
2011 |
Transplantation |
pmid:21508897
|
Keenan RJ et al. |
Immunosuppressive properties of thalidomide. Inhibition of in vitro lymphocyte proliferation alone and in combination with cyclosporine or FK506. |
1991 |
Transplantation |
pmid:1719668
|
David-Neto E et al. |
Longitudinal Pharmacokinetics of Everolimus When Combined With Low-level of Tacrolimus in Elderly Renal Transplant Recipients. |
2017 |
Transplantation |
pmid:27798513
|
McCune TR et al. |
Effects of tacrolimus on hyperlipidemia after successful renal transplantation: a Southeastern Organ Procurement Foundation multicenter clinical study. |
1998 |
Transplantation |
pmid:9448150
|
Mentzer RM et al. |
Tacrolimus as a rescue immunosuppressant after heart and lung transplantation. The U.S. Multicenter FK506 Study Group. |
1998 |
Transplantation |
pmid:9448154
|
Levy G et al. |
Results of lis2t, a multicenter, randomized study comparing cyclosporine microemulsion with C2 monitoring and tacrolimus with C0 monitoring in de novo liver transplantation. |
2004 |
Transplantation |
pmid:15201658
|
Prókai à et al. |
Calcineurin-inhibition Results in Upregulation of Local Renin and Subsequent Vascular Endothelial Growth Factor Production in Renal Collecting Ducts. |
2016 |
Transplantation |
pmid:26502369
|
Ajiki T et al. |
Generation of donor hematolymphoid cells after rat-limb composite grafting. |
2003 |
Transplantation |
pmid:12640301
|
Rush DN et al. |
Factors associated with progression of interstitial fibrosis in renal transplant patients receiving tacrolimus and mycophenolate mofetil. |
2009 |
Transplantation |
pmid:19935461
|
Neylan JF |
Racial differences in renal transplantation after immunosuppression with tacrolimus versus cyclosporine. FK506 Kidney Transplant Study Group. |
1998 |
Transplantation |
pmid:9500626
|
Johnson MC et al. |
QT prolongation and Torsades de Pointes after administration of FK506. |
1992 |
Transplantation |
pmid:1373538
|
Kim YI et al. |
Stimulation of liver regeneration by pretreatment with azathioprine as well as cyclosporine and FK506. |
1992 |
Transplantation |
pmid:1373539
|
D'Antiga L et al. |
Late cellular rejection in paediatric liver transplantation: aetiology and outcome. |
2002 |
Transplantation |
pmid:11792983
|
Butani L et al. |
Effect of felodipine on tacrolimus pharmacokinetics in a renal transplant recipient. |
2002 |
Transplantation |
pmid:11793001
|
Leung W et al. |
Long-term complete remission and immune tolerance after intensive chemotherapy for lymphoproliferative disorders complicating liver transplant. |
1999 |
Transplantation |
pmid:10385092
|
Gupta A et al. |
Elevated myeloid: plasmacytoid dendritic cell ratio associates with late, but not early, liver rejection in children induced with rabbit anti-human thymocyte globulin. |
2009 |
Transplantation |
pmid:19696644
|
Shibutani S et al. |
Effects of immunosuppressants on induction of regulatory cells after intratracheal delivery of alloantigen. |
2005 |
Transplantation |
pmid:15849542
|
Guo Z et al. |
In vivo effects of leflunomide on normal pancreatic islet and syngeneic islet graft function. |
1997 |
Transplantation |
pmid:9075844
|
Mor E et al. |
Late-onset acute rejection in orthotopic liver transplantation--associated risk factors and outcome. |
1992 |
Transplantation |
pmid:1279849
|
Mueller AR et al. |
Neurotoxicity after orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518974
|
Hirano Y et al. |
The effects of FK506 and cyclosporine on the exocrine function of the rat pancreas. |
1992 |
Transplantation |
pmid:1279850
|
Platz KP et al. |
Nephrotoxicity following orthotopic liver transplantation. A comparison between cyclosporine and FK506. |
1994 |
Transplantation |
pmid:7518975
|
Sarwal MM et al. |
Promising early outcomes with a novel, complete steroid avoidance immunosuppression protocol in pediatric renal transplantation. |
2001 |
Transplantation |
pmid:11468528
|
Paramesh AS et al. |
Thrombotic microangiopathy associated with combined sirolimus and tacrolimus immunosuppression after intestinal transplantation. |
2004 |
Transplantation |
pmid:14724447
|
Jain AB et al. |
Comparative incidence of de novo nonlymphoid malignancies after liver transplantation under tacrolimus using surveillance epidemiologic end result data. |
1998 |
Transplantation |
pmid:9825817
|
Franz M et al. |
Posttransplant hemolytic uremic syndrome in adult retransplanted kidney graft recipients: advantage of FK506 therapy? |
1998 |
Transplantation |
pmid:9825827
|
Yoshimura N et al. |
Effect of a new immunosuppressive agent, FK506, on human lymphocyte responses in vitro. I. Inhibition of expression of alloantigen-activated suppressor cells, as well as induction of alloreactivity. |
1989 |
Transplantation |
pmid:2465592
|
Mathis AS et al. |
Sex and ethnicity may chiefly influence the interaction of fluconazole with calcineurin inhibitors. |
2001 |
Transplantation |
pmid:11374405
|
Takatsuki M et al. |
Weaning of immunosuppression in living donor liver transplant recipients. |
2001 |
Transplantation |
pmid:11502975
|
Kovarik JM et al. |
Pharmacokinetics of sotrastaurin combined with tacrolimus or mycophenolic acid in de novo kidney transplant recipients. |
2011 |
Transplantation |
pmid:21157403
|
Ochiai T et al. |
Optimal serum trough levels of FK506 in renal allotransplantation of the beagle dog. |
1989 |
Transplantation |
pmid:2474208
|
Ochiai T et al. |
Effects of combination treatment with FK506 and cyclosporine on survival time and vascular changes in renal-allograft-recipient dogs. |
1989 |
Transplantation |
pmid:2474209
|
Iwata H et al. |
Suppression of allograft responses by combining donor alloantigen-specific intravenous presensitization with suboptimal doses of FK506. |
1993 |
Transplantation |
pmid:7687396
|
Wu MJ et al. |
Lower variability of tacrolimus trough concentration after conversion from prograf to advagraf in stable kidney transplant recipients. |
2011 |
Transplantation |
pmid:21912349
|
Stempfle HU et al. |
The role of tacrolimus (FK506)-based immunosuppression on bone mineral density and bone turnover after cardiac transplantation: a prospective, longitudinal, randomized, double-blind trial with calcitriol. |
2002 |
Transplantation |
pmid:11889427
|
Opelz G and Döhler B |
Effect on kidney graft survival of reducing or discontinuing maintenance immunosuppression after the first year posttransplant. |
2008 |
Transplantation |
pmid:18698238
|
Oike F et al. |
A 12-day course of FK506 allows long-term acceptance of semi-identical liver allograft in inbred miniature swine. |
2000 |
Transplantation |
pmid:10868630
|
Gloor JM et al. |
Subclinical rejection in tacrolimus-treated renal transplant recipients. |
2002 |
Transplantation |
pmid:12131699
|
Charpentier B et al. |
A three-arm study comparing immediate tacrolimus therapy with antithymocyte globulin induction therapy followed by tacrolimus or cyclosporine A in adult renal transplant recipients. |
2003 |
Transplantation |
pmid:12660513
|
Lorber MI et al. |
A comparison of in vivo responses to cyclosporine, FK506, and rapamycin following allogeneic immune challenge. |
1991 |
Transplantation |
pmid:1713364
|
Abu-Elmagd K et al. |
The effect of graft function on FK506 plasma levels, dosages, and renal function, with particular reference to the liver. |
1991 |
Transplantation |
pmid:1713365
|
Jain A et al. |
One thousand consecutive primary liver transplants under tacrolimus immunosuppression: a 17- to 20-year longitudinal follow-up. |
2011 |
Transplantation |
pmid:21378604
|
Gruessner RW et al. |
Portal donor-specific blood transfusion and mycophenolate mofetil allow steroid avoidance and tacrolimus dose reduction with sustained levels of chimerism in a pig model of intestinal transplantation. |
2004 |
Transplantation |
pmid:15239611
|
Chavin KD et al. |
Anti-CD2 monoclonal antibodies synergize with FK506 but not with cyclosporine or rapamycin to induce tolerance. |
1994 |
Transplantation |
pmid:7511258
|
Margreiter R et al. |
A double-hand transplant can be worth the effort! |
2002 |
Transplantation |
pmid:12134104
|
Tian L et al. |
Association of the CD134/CD134L costimulatory pathway with acute rejection of small bowel allograft. |
2002 |
Transplantation |
pmid:12134113
|
Krämer BK et al. |
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial. |
2012 |
Transplantation |
pmid:22858806
|
Wiesner RH |
A long-term comparison of tacrolimus (FK506) versus cyclosporine in liver transplantation: a report of the United States FK506 Study Group. |
1998 |
Transplantation |
pmid:9734494
|
Hodak SP et al. |
QT prolongation and near fatal cardiac arrhythmia after intravenous tacrolimus administration: a case report. |
1998 |
Transplantation |
pmid:9734501
|